Optimizing light dosimetry in photodynamic therapy of early stage carcinomas of the esophagus using fluorescence spectroscopy

Lasers in Surgery and Medicine

Volumn 19, Issue 3, 1996, Pages 340-346

  Braichotte, Daniel R ^a,c   Savary, Jean François ^b   Monnier, Philippe ^b   Van Den Bergh, Hubert E ^a  

^a Inst of Environmental Engineering   (Switzerland)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^c EPFL   (Switzerland)

Author keywords

light dosimetry; mTHPC; photobleaching; photosensitizer

Indexed keywords

PHOTOSENSITIZING AGENT; TETRAKIS(3 HYDROXYPHENYL)CHLORIN;

ARTICLE; BLEACHING; CLINICAL ARTICLE; DOSIMETRY; DRUG BLOOD LEVEL; DRUG TISSUE LEVEL; ESOPHAGUS CARCINOMA; FLUORESCENCE; HUMAN; IRRADIATION; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; SPECTROFLUOROMETRY; TUMOR NECROSIS;

ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; HUMANS; MESOPORPHYRINS; PHOTOCHEMOTHERAPY; RADIATION-SENSITIZING AGENTS; RADIOMETRY; SPECTROMETRY, FLUORESCENCE; TRIAZENES;

EID: 0029953499     PISSN: 01968092     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9101(1996)19:3<340::AID-LSM10>3.0.CO;2-8     Document Type: Article

References (19)

1. Henderson BW, Dougherty TJ. How does photodynamic therapy work. Photochem Photobiol 1992; 55:145-157.
2. van den Bergh H. Photodynamic therapy and photodetection of early cancer in the upper aerodigestive tract, the tracheobronchial tree, the esophagus and the urinary bladder. In: Amaldi U, Larsson B, eds. "Hadrontherapy in Oncology." Amsterdam: Elsevier Science B.V. 1994, pp 577-621.
3. Bonnett R, White RD, Winfield U-J, Berenbaum MC. Hydroporphyrins of the meso-tetra(hydroxyphenyl)porphyrin series as tumor photosensitizers. Bioehem J 1989; 261:277-280.
4. Ris H-B, Altermatt HJ, Inderbitzi R, Hess R, Nachbur B, Steward JCM, Wang Q, Lim CK, Bonnett R, M.C. B, Althaus U. Photodynamic therapy with chlorins for diffuse malignant mesothelioma: initial clinical results. Br J Cancer 1991; 64:1116-1120.
5. Berenbaum MC, Bonnett R, Chevretton EB, Akande-Adebakin SL, Ruston M. Selectivity of meso-tetra(hydroxyphenyl)porphyrins and chlorins and of Photofrin II in causing photodamage in tumor, skin, muscle and bladder. The concept of cost-benefit in analysing the results. Lasers Med Sci 1993; 8:235-243.
6. Ma L, Moan J, Berg K. Evaluation of a new photosensitizer, meso-tetra-hydroxyphenyl-chlorin, for use in photodynamic therapy: A comparaison of its photobiological properties with those of two other photosensitizers. Int J Cancer 1994; 57:883-888,
7. Ris H-B, Altermatt HJ, Nachbur B, Stewart CM, Wang Q, Lim CK, Bonnett R, Althaus U. Effect of drug-light interval on photodynamic therapy with meso-tetrahydroxyphenylchlorine in malignant mesothelioma. Int J Cancer 1993; 53:141-146.
8. Folli S, Westermann P, Braichotte D, Pèlegrin A, Wagnières G, van den Bergh H, Mach J-P. Antibody-indocyanin conjugates for immunophotodetection of human squamous cell carcinoma in nude mice. Cancer Res 1994; 54:2643-2649.
9. Braichotte D, Wagnières G, Bays R, Monnier P, van den Bergh H. Clinical pharmacokinetic studies of Photofrin by fluorescence spectroscopy in the oral cavity, the oesophagus and the bronchi. Cancer 1995; 75:2768-2778.
10. Braichotte D, Savary J-F, Monnier P, van den Bergh H. Enhanced photodynamic therapy and dosimetry by light induced fluorescence. Proc Soc Photo-Opt Instr Eng 1995; 2371:120-124.
11. Beahrs OH, Henson DE, Hutter RVP, Kennedy BJ. "Manual for staging of cancer. (4th ed.)" Philadelphia: J.B. Lippincott, 1992.
12. Mizeret J, Thielen P, Theumann J-F, Bays R, Wagnières G, Savary J-F, Monnier P, van den Bergh H. New distributors for homogeneous and monitorable light delivery in photodynamic therapy. Proc Soc Photo-Opt Instr Eng 1995; 2323:58-69.
13. Brown SB, Vernon DI, Holroyd JA, Marcus S, Trust R, Hawkins W, Shah A, Tonelli A. Pharmacokinetics of Photofrin in man. In: Spinelli P, Dal Fante M, Marchesini R, eds. "Photodynamic Therapy and Biomedical Lasers." Amsterdam: Elsevier Science, 1992, pp 475-479.
14. Pantelides ML, Moore JV, Forbes E, Truscott TG, Blacklock NJ. The uptake of porphyrin and zinc-metalloporphyrin by the primate prostate. Photochem Photobiol 1993; 57:838-841.
15. Wang K, Gutta K, Densmore J. The use of laser induced fluorescence in the determination of photosensitizer concentration during photodynamic therapy of Barrett's esophagus. Lasers Surg Med 1995; S7:42.
16. Braichotte D, Savary J-F, Glanzmann T, Westermann P, Folli S, Wagnières G, Monnier P, van den Bergh H. Clinical pharmacokinetic studies of tetra(meta-hydroxyphenyl)chlorin in squamous cell carcinoma by fluorescence spectroscopy at two wavelengths. Int J Cancer 1995; 63: 198-204.
17. Savary J-F, Monnier P, Wagnières G, Braichotte D, Fontolliet C, van den Bergh H. Preliminary clinical studies of photodynamic therapy with meso-tetraydroxyphenyl chlorin (m-THPC) as a photosensitizing agent for the treatment of early pharyngeal, oesophageal and bronchial carcinomas. Proc Soc Photo-Opt Instr Eng 1993; 2078:330-340.
18. Lam S. Photodynamic therapy of lung cancer. Thorax 1993; 48:469.
19. Bays R, Wagnières G, Robert D, Mizeret J, Braichotte D, van den Bergh H. Clinical measurements of tissue optical properties in the esophagus. Proc Soc Photo-Opt Instr Eng 1995; 2324:39-45.